California State Teachers Retirement System acquired a new stake in shares of AxoGen Inc. (NASDAQ:AXGN) during the second quarter, according to its most recent disclosure with the SEC. The fund acquired 50,593 shares of the company’s stock, valued at approximately $348,000. California State Teachers Retirement System owned about 0.17% of AxoGen at the end of the most recent quarter.
Separately, UBS Group AG raised its stake in shares of AxoGen by 991.7% in the first quarter. UBS Group AG now owns 97,946 shares of the company’s stock valued at $525,000 after buying an additional 88,974 shares in the last quarter. Institutional investors and hedge funds own 57.99% of the company’s stock.
Shares of AxoGen Inc. (NASDAQ:AXGN) remained flat at $8.72 during mid-day trading on Friday. 292,026 shares of the company’s stock traded hands. The firm’s 50 day moving average is $8.74 and its 200-day moving average is $6.99. The company’s market cap is $262.75 million. AxoGen Inc. has a 12-month low of $4.08 and a 12-month high of $9.88.
AxoGen (NASDAQ:AXGN) last posted its earnings results on Wednesday, August 3rd. The company reported ($0.09) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.12) by $0.03. AxoGen had a negative net margin of 37.90% and a negative return on equity of 193.60%. Equities research analysts forecast that AxoGen Inc. will post ($0.40) EPS for the current year.
Separately, Wedbush reiterated an “outperform” rating and set a $10.00 price objective (up previously from $9.00) on shares of AxoGen in a report on Thursday, August 4th.
In related news, CEO Karen L. Zaderej bought 10,000 shares of the company’s stock in a transaction that occurred on Friday, October 7th. The stock was purchased at an average price of $7.50 per share, for a total transaction of $75,000.00. Following the acquisition, the chief executive officer now owns 242,147 shares of the company’s stock, valued at $1,816,102.50. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Amy Mcbride Wendell bought 13,333 shares of the company’s stock in a transaction that occurred on Friday, October 7th. The stock was bought at an average price of $7.50 per share, with a total value of $99,997.50. Following the acquisition, the director now directly owns 13,333 shares in the company, valued at approximately $99,997.50. The disclosure for this purchase can be found here. 9.33% of the stock is currently owned by corporate insiders.
Want to see what other hedge funds are holding AXGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AxoGen Inc. (NASDAQ:AXGN).
Receive News & Ratings for AxoGen Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AxoGen Inc. and related companies with MarketBeat.com's FREE daily email newsletter.